September 2015

Chairman's Note
Chairman's Note
Michael J. Hennessy
From the Editor
From the Editor
Debu Tripathy, MD
Breast Cancer Immunotherapy: Is It Ready for Prime Time?
Elizabeth A. Mittendorf, MD, PhD; Kelly K. Hunt, MD
PD-1 and PD-L1 Inhibitors: Activity as Single Agents and Potential Biomarkers in Non-Small Cell Lung Cancer
Antiangiogenesis and Future Combinations with Anti-Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer
Edward S. Kim, MD
Prostate Cancer
Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer?
Bobby C. Liaw, MD; William K. Oh, MD
Clinical Controversies
Putting the "Great Mammography Debate" to Rest
Carlie K. Thompson, MD; Martin Eklund, PhD; Laura J. Esserman, MD, MBA